Shimizu Y, Ando M, Watanabe H, Ono M, et al. Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer. Ann Nucl Med 2024 Jul 8. doi: 10.1007/s12149-024-01959.
PMID: 38976087